Home
About Us
Company News
Contact Us
Expanded Access Program
Home
About Us
Company News
Contact Us
Expanded Access Program
中文/EN
Company News
In the Press
Learn More
2025-08-11
The Galien Foundation Announces 2025 Prix Galien USA Nominees for "Best Biotechnology Product," "Best Pharmaceutical Product" and "Best Product for Rare/Orphan Diseases"
Learn More
2021-10-29
Signet Therapeutics gets a $10M top-up for next-gen cancer bets
Learn More
News
Learn More
2025-11-07
Signet Therapeutics Wins BioTech Breakthrough Award For “Drug Discovery Innovation Award”
Learn More
2025-04-01
Preclinical Data on SIGX1094, the First Targeted Therapy for Diffuse Gastric Cancer, to be Presented at AACR 2025
Learn More
2025-02-25
Expanded Access Policy
Learn More
